Td Private Client Wealth LLC Sage Therapeutics, Inc. Transaction History

Td Private Client Wealth LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2024	BUY	$54.88 - $79.29 $164 - $237	3 Added 15.0%	23 $1.31 Million
Q1 2021 Aug 16, 2024	SELL	$70.65 - $96.76 $494 - $677	-7 Reduced 25.93%	20 $1.5 Million
Q4 2020 Aug 16, 2024	BUY	$58.41 - $89.06 $700 - $1,068	12 Added 80.0%	27 $2.34 Million
Q3 2020 Aug 16, 2024	BUY	$41.13 - $62.45 $329 - $499	8 Added 114.29%	15 $917,000
Q2 2020 Aug 16, 2024	SELL	$25.95 - $43.15 $233 - $388	-9 Reduced 56.25%	7 $291,000
Q1 2020 Aug 16, 2024	BUY	$26.15 - $77.24 $104 - $308	4 Added 33.33%	16 $460,000
Q4 2019 Aug 16, 2024	BUY	$60.18 - $154.77 $722 - $1,857	12 New	12 $866,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.